Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT00579566
- Status
- Recruiting
Conditions
- Sarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Specimen protocol — OTHERThe research specimen will be obtained from the residual specimen that would otherwise be discarded per usual hospital procedure.
Study Details
The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue left over after all needed testing has been done or remove an additional small amount of tissue if you are having a biopsy. We will also take blood samples before and/or after your procedure to measure biochemical factors that may help us predict the behavior of sarcoma.
Key Dates
- Start date
- Jun 30, 2002
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 3,000 participants (estimated)
Arms
- Arm: 1Sarcoma patients undergoing core biopsy, incisional biopsy or definitive surgical resection for soft tissue masses of extremity, trunk or retroperitoneum
Primary Outcome Measure
establish and maintain a specimen bank and sarcoma cell line resource [ Time Frame: 2 years ]
Central Contacts
- Samuel Singer, MD212-639-2940
- Aimee Crago, MD, PhD
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) | Basking Ridge | New Jersey | 07920 | Samuel Singer, MD 212-639-2940 |
| Memorial Sloan Kettering Monmouth (Consent and Followup) | Middletown | New Jersey | 07748 | Samuel Singer, MD 212-639-2940 |
| Memorial Sloan Kettering Bergen (Consent and Follow up) | Montvale | New Jersey | 07645 | Sam Singer, MD 212-639-2940 |
| Memorial Sloan Kettering Commack (Consent and Follow-Up) | Commack | New York | 11725 | Samuel Singer, MD 212-639-2940 |
| Memorial Sloan Kettering Westchester (Consent and Followup) | Harrison | New York | 10604 | Samuel Singer, MD 212-639-2940 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | 10065 | Samuel Singer, M.D. 212-639-2940 Samuel Singer, M.D. (PRINCIPAL_INVESTIGATOR) |
| Memorial Sloan Kettering Nassau (Consent and Followup) | Rockville Centre | New York | 11553 | Sam Singer, MD 212-639-2940 |
Find similar trials in Basking Ridge, NJ
Related Studies
- Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological StudiesRecruiting · National Cancer Institute (NCI) · Washington D.C., District of Columbia
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyPHASE4 · Enrolling By Invitation · Massachusetts General Hospital · Los Angeles, California
- Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With SarcomaPHASE1/PHASE2 · Recruiting · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · St. Petersburg, Florida